Posted by Michael Wonder on 26 Jul 2020
Debating drug prices in the shadow of coronavirus: access versus innovation. Can both sides win?
24 July 2020 - In fact, the pandemic has shown that both sides must win.
Without new medicines the country will suffer terrible loss personally, socially and economically.
However, the biopharmaceutical industry cannot defeat disease—be it COVID-19 or cancer— if the health care system cannot deliver treatment to everyone in need.
